ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLausanneReproNovo SA
ReproNovo SA Logo
Verified· 3 sources

ReproNovo SA

Summary

About the company

The core activity of ReproNovo is the development of innovative solutions for reproductive medicine and women's health, particularly the treatment of infertility and adenomyosis. The company focuses on developing therapeutic approaches to improve the success rates of assisted reproductive technologies and to develop new treatment options for men with hypogonadism and women with adenomyosis.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
5
Development of Therapies for Fertility and Gynaecology
Development of new therapeutic solutions for male and female fertility as well as gynaecology, focusing on unmet medical needs and indications that are insufficiently treated.
Therapy Development for Male Fertility
Oral drug programmes for the treatment of male infertility with low testosterone, to promote sperm production and improve the chances of pregnancy.
Therapy Development for Embryo Implantation
Oral therapy to improve embryo implantation following ART, with the aim of increasing pregnancy and live birth rates.
Therapy Development for Adenomyosis
Oral, non-surgical treatment of adenomyosis symptoms, in particular to relieve dysmenorrhoea and other uterine complaints.
In-licensing and Out-licensing
Partnerships for in-licensing and out-licensing of programmes in fertility and gynaecology, including strategic alliances for advanced clinical assets.
Press

Media

May 21, 2025Media
ReproNovo raises USD65 million to advance Phase II clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once ReproNovo SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

ReproNovo SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank ReproNovo SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of ReproNovo SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Rue de Langallerie 11
1003 Lausanne
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-198.216.736
Founded
2021 · 5 years
Last commercial register change
July 2, 2026
Employees
11 to 20

Similar companies

AT
Avrion Therapeutics SA
Lausanne
LL
LRK Laboratoire homéopathique de recherches Kurtoglu SA
Cugy Vd
OS
Oligopharm SA
Cugy Vd
IB
Incyte Biosciences International Sàrl
Morges
AD
Association de la Pharmacie des Hôpitaux de l'Est Lémanique
Rennaz
AB
AB2 Bio SA
Lausanne
AT
ADC Therapeutics SA
Epalinges
AS
Asceneuron SA
Eysins